Organization Profile

You just read:

Health Canada Approves Strensiq™ (asfotase alfa), the First Therapy for Patients with Hypophosphatasia (HPP), an Ultra-rare, Life-threatening Disease

News provided by

Alexion Pharma Canada

Aug 17, 2015, 07:30 ET